Background
==========

Infection by many enveloped viruses requires fusion of the viral and cellular membranes. A viral envelope protein mediates this membrane fusion process. These proteins are synthesized as precursors (ENV in Retroviridae, and E2 in Coronaviridae) that are later processed into a transmembrane subunit (gp41 in the retrovirus HIV-1, and S2 in the coronavirus SARS-CoV) that is responsible for viral-induced membrane fusion, and a surface subunit that is responsible for the interaction with the cellular receptor/s.

HIV-1 gp41, which is a well-characterized protein \[[@B1],[@B2]\] contains two heptad repeat (HR) regions, a leucine/isoleucine HR adjacent to its N-terminus (N-HR), and C-HR proximal to the transmembrane domain (see Figure [1](#F1){ref-type="fig"}). Heptad repeats are characterized by hydrophobic amino acids in the \"a\" and \"d\" positions of the helix. In the N-HR of gp41, all but one of the \"a\" positions are Leucines or Isoleucines. This feature is less strict in the \"d\" positions of N-HR, and in the \"a\" and \"d\" positions of the C-HR. Peptides corresponding to these heptad repeat regions form the \"trimer-of-hairpins\" core structure of gp41 \[[@B3]\] as confirmed by the solution of the crystal structures \[[@B1],[@B2]\]. Two Cysteine residues and one Proline residue, located between these two HRs, confine a hairpin conformation (Figure [2a](#F2){ref-type="fig"}). A tryptophan-rich motif, located between the C-HR and the transmembrane domain, was shown to play a crucial role in gp41-mediated membrane fusion \[[@B4]\] (Figure [2a](#F2){ref-type="fig"}).

In order to exert their role in membrane fusion, viral spike proteins act as oligomers and go through a significant conformational change resulting in the \"trimer-of-hairpin\" conformation. The oligomerization and the change in conformation of viral spike proteins involve interactions between proteins segments. Peptides derived from a segment of this protein might therefore interfere with one of these processes, and inhibit viral infection. Indeed, peptides corresponding to the C-HR of gp41 are potent inhibitors of HIV-1 entry into cells, one of them, Enfuvirtide (Fuzeon), was recently approved by the FDA as an addition to the cocktail currently given to AIDS patients \[[@B5]\], and C34, a peptide corresponding to the C-HR of the gp41 core complex is promising in-vitro \[[@B1]\]. It is believed that these peptides exert their anti-viral activity via a dominant negative mechanism by interacting with the central N-HR segment of gp41 \[[@B6]\]. This is a promising approach also in developing anti-viral peptides against several paramyxoviruses \[[@B7]\].

The genome of the SARS-CoV was recently sequenced \[[@B8],[@B9]\]. Since it is a member of the Coronaviridae \[[@B10]\], the S2 protein is believed to play a central role in viral entry. Although we found no sequence homology between the SARS-CoV S2 and HIV-1 gp41, a comprehensive sequence analysis reveals that all the above-mentioned elements of gp41 are present also in S2.

In analogy to HIV-1 gp41, N-HR and an aromatic-rich region in SARS-CoV S2 protein were identified by Gallaher & Garry \[[@B11]\]. Whereas these discoveries have structural importance, peptides corresponding to the N-HR of HIV-1 \[[@B12]\] and Sendai virus \[[@B13]\], and to the aromatic-rich region of feline immunodeficiency virus \[[@B14]\] were found to have only low anti-viral activity, compared to the highly active C-HR corresponding peptides.

Herein, we report the identification of the sequence in SARS-CoV S2 protein that is analogous to the C-HR of HIV-1 gp41. This led us to the suggestion that the viral entry mechanisms are analogous and therefore a therapeutic strategy that is being applied against the HIV-1 can be adopted to fight SARS-CoV.

Results and discussion
======================

Coronaviridae S2 proteins are believed to be functionally equivalent to the transmembrane subunits of Retroviral ENV. However, using well-known sequence comparison algorithms \[[@B15],[@B16]\], we found that there is no sequence homology between the S2 protein of SARS-CoV and HIV-1 gp41.

Markedly, LearnCoil-VMF \[[@B17]\], helical wheel analysis and protein topology prediction \[[@B18]\] reveal that the SARS-CoV S2 protein consists of the same elements that were characterized in HIV-1 gp41 (Figure [2b](#F2){ref-type="fig"}): (I) N-HR, a Leucine/Isoleucine heptad repeat appears on residues 913--1000 of the SARS-CoV CUHK-W1 isolate (Figure [3a](#F3){ref-type="fig"}).; (II) C-HR, a Leucine/Isoleucine heptad repeat appears on residues 1151--1185 (Figure [3b](#F3){ref-type="fig"}); (III) the loop between these two HRs is longer than that of gp41, and is confined by four Cysteine residues and nine Proline residues that might conform a double loop structure; (IV) a transmembrane region is predicted adjacent to the C-terminus of the protein \[[@B18]\]; (V) a Tryptophan/Tyrosine-rich motif is located between the C-HR and the transmembrane domain (Figure [4](#F4){ref-type="fig"}). The results reveal similar structural motifs in HIV-1 gp41 and SARS-CoV S2 proteins, suggesting an analogous membrane fusion mechanism induced by the two viruses.

The helical wheel diagram serves as an equivalent to the Spartan *scytale*, the first military cryptographic device, consisting of a cylinder with a strip of paper wound around it. The recipient has a rod of the same diameter, on which he wraps the paper to read the message. Herein, the prior knowledge of the 3.5 periodicity learned from the HIV-1 gp41 structural studies, is used to decipher the structural features of the SARS-CoV S2 protein.

In general, SARS-CoV S2 and HIV-1 gp41 share the hairpin structure. However, it is worth noting that the N-HR of S2 is longer than that of gp41 and contains more Leucines and Isoleucines. Furthermore, while the C-HR of gp41 barely shows any heptad repeat signal, the C-HR of S2 has a perfect Leucine/Isoleucine heptad repeat in its \"d\" positions.

The antiviral activity of Enfuvirtide was reported as early as 1993 \[[@B19]\], while it took few years until the fold of gp41 core complex was discovered \[[@B3]\] and its crystal structure being solved \[[@B1],[@B2]\]. Based on these structural studies, peptides corresponding to the C-HR of gp41 core complex, such as C34, were synthesized and found to efficiently inhibit HIV-1 induced membrane fusion \[[@B1]\]. Interestingly, Enfuvirtide, which is a shifted version of these C-peptides, does not comprise the residues that were shown to be essential for their inhibitory activity \[[@B20]\]. Indeed, others and myself reported that in some cases C34 is more potent in inhibiting HIV-1 gp41 induced membrane fusion than Enfuvirtide \[[@B21],[@B22]\]. Thus, the SARS-CoV sequence corresponding to C34 has higher chances to block SARS-CoV entry.

Conclusions
===========

Based on the similarity in the mechanisms in which the two viruses induce fusion between their membrane and their host cell membrane, we propose adapting the successful anti-fusion therapeutic approach used against HIV-1 to the SARS-CoV case. Peptides derived from the C-HR segment of SARS-CoV S2 protein (ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL) might inhibit viral induced membrane fusion, thereby blocking SARS-CoV infection. As the SARS-CoV infects respiratory tissues, the classical disadvantages of peptide therapeutics administration may be overcome using intranasal delivery \[[@B23]\].

Methods
=======

Heptad repeat analysis
----------------------

LearnCoil-VMF program \[[@B17]\] and helical wheel diagrams, with 3.5 amino acid per residue, were used to detect coiled-coil regions in the SARS-CoV S2 protein.

Transmembrane domain prediction
-------------------------------

HMMTOP program \[[@B18]\] was used to predict the location of transmembrane regions in the SARS-CoV S2 protein.

Protein sequences
-----------------

SARS-CoV genomic sequence information (NC_004718) was retrieved from GenBank at the National Center for Biotechnology Information (NCBI). The SARS-CoV E2 precursor protein accession number is gi\|30023954. This precursor is believed to be post-translationally processed to reveal S1 and S2, as confirmed in other Coronaviridae viruses.

The HIV-1 gp160 precursor protein sequence used here is gi\|9629363. Gp41 starts at residue 512, after the basic cleavage site.

List of abbreviations
=====================

SARS-CoV: Severe Acute Respiratory Syndrome Coronaviridae Virus.

FDA: US Food & Drug Administration.

HIV-1: Human Immunodeficiency Virus Type 1.

HR: Heptad Repeat.

Authors\' contributions
=======================

Y.K. was responsible for the initiation of this project. E.Y.L. & Y.K. carried out the technical work, analyzed the data, drafted the manuscript and approved the final manuscript.

Acknowledgements
================

We thank Eli Eisenberg, Salomon Langer, Rodrigo Yelin, Moshe Olshansky and Rotem Sorek for helpful discussions. We are also grateful to Amit Rubinfeld for technical help.

Figures and Tables
==================

![Wheel projection of the N-HR (a) and C-HR (b) of HIV-1 gp41 (gi\|9629363). The amino acid sequence is displayed end-to-end down the axis of a schematic helix. The angle between every two consecutive amino acids is 102.9°. The helical wheel consists of seven corners, corresponding to the fit of seven amino acid residues into every two helical turns.](1471-2180-3-20-1){#F1}

![Similarity between the fusion proteins of HIV-1 and SARS-CoV. The HIV-1 gp41 (a) and the equivalent S2 protein from the SARS-CoV (b) are shown. A Leucine/Isoleucine heptad repeat adjacent to the N-terminus of both proteins appears in red. The C-terminal heptad repeat is in green. Cysteine residues (purple) confining a loop structure are located between the two heptad repeats. An aromatic residues-rich motif is marked blue, and the transmembrane segment is in orange. A peptide corresponding to the C-terminal heptad repeat, which acts as potent inhibitor of HIV-1 entry into the cell, appears in yellow.](1471-2180-3-20-2){#F2}

![Wheel projection of the N-HR (a) and C-HR (b) of SARS-CoV S2 protein (gi\|30023954). The amino acid sequence is displayed end-to-end down the axis of a schematic helix. The angle between every two consecutive amino acids is 102.9°. The helical wheel consists of seven corners, corresponding to the fit of seven amino acid residues into every two helical turns.](1471-2180-3-20-3){#F3}

![Sequence comparison of the aromatic residue-rich regions of HIV-1 gp41 and SARS-CoV S2 proteins. The aromatic residues are in blue. Remarkably, the relatively rare aromatic residues comprise about half of the residues in these region.](1471-2180-3-20-4){#F4}
